MASS

908 Devices Inc. NASDAQ Listed Dec 18, 2020

Healthcare ·Medical - Devices ·US · 908devices.com

$8.08

Mkt Cap $302.0M

52w Low $4.20 75.5% of range 52w High $9.34

50d MA $6.64 200d MA $6.67

P/E (TTM) 12.6x

EV/EBITDA -4.4x

P/B 1.7x

Debt/Equity 0.1x

ROE 13.6%

P/FCF -7.7x

RSI (14) —

ATR (14) —

Beta 0.53

50d MA $6.64

200d MA $6.67

Avg Volume 275.7K

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

SIC Code

3829

CIK (SEC)

1555279

Phone

857 254 1500

645 Summer Street · Boston, MA 02210 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 6, 2026	BMO	-0.15	-0.22	-46.7%	7.09	+7.1%	+13.7%	+0.2%	+1.1%	—	—	—
Mar 3, 2026	BMO	-0.06	-0.05	+16.7%	6.32	+0.0%	+6.6%	+0.1%	-7.3%	+1.8%	-1.7%	—
Nov 10, 2025	BMO	-0.12	-0.15	-30.4%	6.40	-2.3%	-7.8%	+0.0%	-1.5%	-5.7%	-1.8%	—
Aug 5, 2025	BMO	-0.16	-0.18	-12.5%	6.34	+3.3%	+3.2%	-1.8%	-1.4%	+1.6%	+0.6%	—
May 13, 2025	BMO	-0.27	-0.22	+18.5%	4.65	+1.1%	-7.1%	+4.6%	+1.3%	+4.1%	+3.6%	—
Mar 4, 2025	BMO	-0.35	-0.32	+8.6%	3.88	+4.1%	-13.1%	-10.7%	-8.3%	+9.4%	+14.6%	—
Nov 12, 2024	BMO	-0.29	-0.23	+20.7%	2.92	-3.4%	-19.9%	+1.7%	+0.4%	-1.3%	+5.1%	—
Aug 6, 2024	BMO	-0.34	-0.32	+5.9%	4.63	+3.5%	-5.0%	+0.5%	-1.6%	-2.3%	+0.0%	—
Apr 30, 2024	BMO	-0.37	-0.33	+10.8%	5.70	-0.4%	-0.4%	-0.2%	-0.4%	-0.5%	+1.4%	—
Mar 5, 2024	BMO	-0.27	-0.23	+14.8%	6.96	+1.4%	+2.7%	-2.9%	-1.2%	-2.9%	+5.4%	—
Nov 7, 2023	BMO	-0.30	-0.22	+26.7%	6.16	+0.4%	-8.7%	-11.8%	+6.0%	+7.6%	+19.1%	—
Aug 8, 2023	BMO	-0.33	-0.29	+12.1%	7.65	+0.3%	-3.5%	-0.9%	-1.4%	-1.7%	-0.4%	—
May 9, 2023	AMC	-0.35	-0.39	-11.4%	7.58	+2.2%	+2.1%	-2.6%	-0.8%	-2.1%	-5.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 5	Leerink Partners	Upgrade	Market Perform → Outperform	—	$6.52	$6.45	-1.1%	-2.8%	+3.2%	-1.8%	-1.4%	+1.6%
Jan 15	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.98	$2.52	+27.3%	+47.0%	-0.3%	+2.8%	+1.7%	-7.3%
Nov 13	Leerink Partners	Downgrade	Outperform → Market Perform	—	$2.92	$2.82	-3.4%	-19.9%	+1.7%	+0.4%	-1.3%	+5.1%
Nov 13	Stifel	Maintains	Buy → Buy	—	$2.92	$2.82	-3.4%	-19.9%	+1.7%	+0.4%	-1.3%	+5.1%
Oct 17	Leerink Partners	Maintains	Outperform → Outperform	—	$3.53	$3.53	+0.0%	-2.8%	+4.7%	-2.5%	-2.0%	-0.6%
May 13	Stephens & Co.	Maintains	Overweight → Overweight	—	$5.70	$5.81	+1.9%	+15.1%	+9.0%	+1.3%	-5.0%	-0.4%
Sep 25	Stephens & Co.	Maintains	Overweight → Overweight	—	$6.04	$6.00	-0.7%	+0.2%	+0.8%	+6.2%	-0.9%	+3.7%
Feb 7	Stephens & Co.	Maintains	Overweight → Overweight	—	$9.97	$10.09	+1.2%	+4.4%	-0.6%	-2.4%	+0.5%	+2.1%
Jan 6	SVB Leerink	Maintains	Outperform → Outperform	—	$7.45	$7.51	+0.8%	-1.9%	+0.1%	+11.3%	+2.3%	-2.0%
Nov 15	SVB Leerink	Maintains	Outperform → Outperform	—	$12.48	$12.70	+1.8%	-15.9%	+4.9%	-5.3%	-5.1%	-0.1%
Mar 8	SVB Leerink	Maintains	Outperform → Outperform	—	$15.54	$16.34	+5.1%	+15.1%	+6.7%	-1.0%	-1.6%	-7.9%
May 14	SVB Leerink	Maintains	Outperform → Outperform	—	$36.75	$38.03	+3.5%	+0.2%	-0.4%	+2.4%	-1.9%	+3.3%
Jan 12	Cowen & Co.	Maintains	Outperform → Outperform	—	$56.63	$57.42	+1.4%	+0.9%	+0.8%	+6.6%	+1.7%	+3.9%
Jan 12	Stifel	Maintains	Buy → Buy	—	$56.63	$57.42	+1.4%	+0.9%	+0.8%	+6.6%	+1.7%	+3.9%
Jan 12	SVB Leerink	Maintains	Outperform → Outperform	—	$56.63	$57.42	+1.4%	+0.9%	+0.8%	+6.6%	+1.7%	+3.9%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 6, 2026	Brown Christopher D.	—	Sell	20,000	$7.23	$145K	925,559	+1.11%	—
May 1, 2026	Kenneweg John	SVP, Sales & Product Marketing	Sell	7,787	$6.83	$53K	76,039	+8.24%	—

Data updated apr 25, 2026 8:36pm · Source: massive.com